Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Jun 21, 2021

SELL
$242.95 - $284.63 $550,281 - $644,686
-2,265 Closed
0 $0
Q4 2020

Jun 15, 2021

BUY
$236.26 - $355.63 $535,128 - $805,501
2,265 New
2,265 $555,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $17.2B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Heartland Bank & Trust CO Portfolio

Follow Heartland Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heartland Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Heartland Bank & Trust CO with notifications on news.